A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer

NCT06344351 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Neoplasm

Interventions

DRUG: TQB3006 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.